in tumor development. DAMPs may signal through the receptor for advanced glycation end products (Rage). Similar to TLRs, Rage is located on the plasma membrane and although its extracellular domain is distinct from the conserved region of TLRs, the effects of Rage and TLR signaling are comparable, and may even be mediated through the same adaptor molecule, MyD88. 4 The development of colitis-associated tumors is driven by the innate immune system, both PAMPs and DAMPs contributing to tumor formation. 2, 5 More surprisingly, innate immunity also plays a pivotal role in sporadic intestinal tumorigenesis. 6 In the intestine of mice in which TLRsignaling is incapacitated by the absence of the adaptor molecule MyD88, tumor development is markedly attenuated. However, the receptors or ligands that activate the innate immune system in this setting have not been identified to date.
Tumors have been described as wounds that do not heal and the tumor environment contains a high level of cellular damage signals. 7, 8 Tumor cells actively produce or passively allow for the release of DAMPs, which may signal to sustain a tumorigenic environment. We have explored the role of DAMPs that signal through Rage in a model of sporadic intestinal tumorigenesis. 9 We crossed mice that lack Rage due to homologous recombination (Rage -/-) to Apc Min/+ mice, harboring a truncating mutation in the adenomatous polyposis coli (Apc) gene, which is often the first gene mutated in the development of colon cancer in humans. Apc Min/+ mice that lack Rage had a 58% reduction in polyp number as compared with control animals. Apc Min/+ Rage -/-animals exhibit a marked increase in tumor cell apoptosis, suggesting that their phenotype may reflect a role for Rage signaling in the survival of tumor cells. To investigate whether the levels of DAMPs are increased in tumors, we analyzed expression of a number of molecules that are known activators of Rage, including Hmgb1, S100a8 and S100a9. Comparing mRNA expression in tumors and normal tissue, Hmgb1 and S100a8, but not S100a9, were upregulated in tumors. Surprisingly, such upregulation was not observed in tumors developing in Rage-deficient animals. Finally, since skin tumor development through Rage is known to depend on immune cell infiltration, 10 we analyzed the effect of Rage signaling on the composition of the immune cell infiltrate in intestinal polyps. Although Rage -/-polyps did not exhibit altered infiltration of neutrophils, macrophages or T-lymfocytes, we found a surprising 14-fold upregulation in tumorinfiltrating mast cells in the adenomas
In the intestine, a large variety of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) can instigate innate immune responses, which have been shown to promote colorectal carcinogenesis. we have recently demonstrated an important role for the receptor for advanced glycation end products (rage) in intestinal adenoma formation. rage is a receptor for DAMPs that are are present in several proteins produced in intestinal adenomas. we found that rage signaling upholds a pro-inflammatory milieu through a feed-forward loop that stimulates the production of its own ligands.
and plays a role in intestinal tumorigenesis (Fig. 1) . Mice that lack Rage fail to develop such a tissue damage response and they exhibit lower rates of tumor formation. Blocking DAMP signaling may thus diminish the activation of the innate immune system during tumor development and hence inhibit tumorigenesis. Thus, Rage may constitute a therapeutic target for the treatment of sporadic intestinal cancers.
self-sustaining pro-inflammatory feed-forward signaling loop. Third, in the absence of this inflammatory milieu, mast cells appear to infiltrate tumors. These cells may be involved in the protection from tumorigenesis that we observed in Rage -/-animals, this remains speculative.
Our work identified a feed-forward proinflammatory loop that activates a tissue damage response through Rage signaling from Rage -/-mice, compared with their Rage-proficient counterparts.
Our findings have implications for various aspects of sporadic tumor development in the intestine. Most importantly, DAMPs from the tumor environment activate Rage signaling and thereby contribute to tumorigenesis, perhaps by conferring survival signals to cancer cells. Second, DAMP signaling in tumors through Rage activates a Figure 1 . rage signaling in intestinal tumorigenesis. In the healthy intestinal epithelium (A), low levels of damage-associated molecular patterns (DAMPs) fail to activate rage. In intestinal adenomas (B), high levels of DAMPs derive from damaged or dying cells. these DAMPs activate rage, which increases the production of DAMPs such as hMGB1 and s100, which in turn sustain an inflammatory and pro-tumorigenic milieu. In the absence of rAGe (C), DAMPs fail to initiate an inflammatory response, resulting in limited tumorigenesis.
